HealthScienceTechnologyWorld

Global Active Pharmaceutical Ingredients (API) Market || keyplayers Eli Lilly and Company AbbVie Inc. Merck & Co., Inc.

An active pharmaceutical ingredient (API) is a drug or mixture of drugs applicable in a finished pharmaceutical product (FPP). API is a biologically active ingredient within the drug product intended for the treatment, diagnosis, or prevention of a disease. It is the definite component liable for the desired effect it has on the subject using it.

Rising prevalence of infectious diseases, cardiovascular conditions, and other chronic disorders among individuals globally is the major factor driving growth of the global market. In addition, due to rising prevalence of cancer, several manufacturers are focusing on development of highly potent APIs (HPAPI) and specialty APIs, thus boosting growth of the global market. According to data published by World health organization, cancer is the second leading cause of death globally and is projected to account for 9.6 million deaths in 2018. Furthermore, large numbers of drugs are in the pipeline to develop treatments for cancer, autoimmune disorder, and metabolic diseases. Increasing healthcare expenditure and rising geriatric population in developing countries are expected to enhance growth of the target market over the forecast period. However, increasing penetration of counterfeit drugs and unfavorable drug price control policies across various countries is expected to hamper growth of the global active pharmaceutical ingredients (API) market over the forecast period. Nevertheless, increasing demand toward the development of complex APIs used in novel formulations, targeting niche therapeutic areas is the major trend observed for the growth of the target market.

Request free sample:-https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3709
  1. Global Active Pharmaceutical Ingredients (API) Market, By Type, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Generic
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Branded
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  2. Global Active Pharmaceutical Ingredients (API) Market, By Business Mode, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Captive API
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Merchant API
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  3. Global Active Pharmaceutical Ingredients (API) Market, By Synthesis Type, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Synthetic
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Biotech
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  4. Global Active Pharmaceutical Ingredients (API) Market, By Application, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Cardiology
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Pulmonology
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Oncology
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Ophthalmology
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Neurology
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Orthopedic
      • Overview
      • Market Business Mode and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Company Profile:
      • Teva Pharmaceutical Industries Ltd. *
            • Company Overview
            • Product Portfolio
            • Key Highlights
            • Financial Performance
      • Sanofi
      • Pfizer, Inc.
      • Bristol-Myers Squibb
      • Novartis AG
      • Boehringer Ingelheim
      • GlaxoSmithKline plc
      • Eli Lilly and Company
      • AbbVie Inc.
      • Merck & Co., Inc.
  5. Contact Us:

    Mr. Alex (Sales Manager)

    Prophecy Market Insights

    Phone: +1 860 531 2701

    +91 777 504 9802
    Email: sales@prophecymarketinsights.com

Back to top button